During the past decade, Quad Clinical Research conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Quad Clinical Research" are "COVID-19" (2 trials), "Mild-to-Moderate COVID-19" (1 trials) and "Viral Respiratory Illnesses" (1 trials). Many other conditions were trialed in "Quad Clinical Research" in a lesser frequency.

Most popular intervention types in "Quad Clinical Research" are "Other" (2 trials), "Dietary Supplement" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Self Supportive Care (SSC) Alone" (2 trials), "KB109 + Self Supportive Care" (1 trials), "KB109 + Self Supportive Care (SSC)" (1 trials), "Nitazoxanide" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Quad Clinical Research" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Quad Clinical Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Quad Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Quad Clinical Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".